Sodium Nitroprusside Injection
Product Images NDC 72485-105

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 72485-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72485105 2

Sodium Nitroprusside Injection 50 mg/2 mL Vial (25 mg/mL) packaging label and outer carton label by Armas Pharmaceuticals Inc. The labels indicate the drug is for intravenous infusion only and must be diluted. The carton includes dilution instructions, storage conditions, and barcode. Manufactured by Micro Labs Limited, India and distributed by Armas Pharmaceuticals, USA.*

FDA Label Image

Figure (Sodiumnitroprussidefigure)

Diagram illustrating the metabolism of Sodium Nitroprusside showing its interaction with active cytochromes, conversion to cyanide, cyanmethemoglobin, methemoglobin, thiocyanate, and thiosulfate, including pathways for renal excretion and involvement of rhodanase enzyme.*

FDA Label Image

Structure (Sodiumnitroprussidestructure)

Chemical structure diagram of sodium nitroprusside showing its iron core complexed with cyanide (CN) and nitric oxide (ON) ligands, two sodium ions (Na+), and two water molecules (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.